Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EXAS – Exact Sciences Corporation

Exact Sciences Corporation
EXAS
$67.34
Name : Exact Sciences Corporation
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $12,758,049,792.00
EPSttm : -5.35
finviz dynamic chart for EXAS
Exact Sciences Corporation
$67.34
0.46%
$0.305

Float Short %

4.25

Margin Of Safety %

-32

Put/Call OI Ratio

1.01

EPS Next Q Diff

-0.16

EPS Last/This Y

6.02

EPS This/Next Y

0.68

Price

67.04

Target Price

83.65

Analyst Recom

1.44

Performance Q

48.66

Relative Volume

0.65

Beta

1.45

Ticker: EXAS




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20EXAS62.730.990.7236462
2025-10-21EXAS63.420.980.2637315
2025-10-22EXAS62.90.970.5437879
2025-10-23EXAS64.850.970.6538107
2025-10-24EXAS64.640.970.3238547
2025-10-27EXAS63.470.970.1637606
2025-10-28EXAS63.310.980.5437615
2025-10-29EXAS62.721.000.2737530
2025-10-30EXAS63.221.000.2237696
2025-10-31EXAS64.691.000.6337780
2025-11-03EXAS66.991.010.4936832
2025-11-04EXAS69.560.980.4439381
2025-11-05EXAS69.611.030.4340577
2025-11-06EXAS67.21.030.4540934
2025-11-07EXAS66.181.030.5341079
2025-11-10EXAS66.571.080.9938431
2025-11-11EXAS67.331.090.3238950
2025-11-12EXAS68.381.050.4239361
2025-11-13EXAS67.761.060.2039678
2025-11-14EXAS67.031.010.4840783
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20EXAS62.73226.51170.60.36
2025-10-21EXAS63.42225.41168.40.37
2025-10-22EXAS62.91225.41165.20.37
2025-10-23EXAS64.85225.41171.70.37
2025-10-24EXAS64.65225.41166.00.37
2025-10-27EXAS63.49225.41163.50.37
2025-10-28EXAS63.30225.41166.00.37
2025-10-29EXAS62.72225.41165.00.37
2025-10-30EXAS63.22225.41167.80.37
2025-10-31EXAS64.69225.41170.40.37
2025-11-03EXAS66.99225.41172.50.37
2025-11-04EXAS69.56225.41173.00.37
2025-11-05EXAS69.63225.41166.60.37
2025-11-06EXAS67.21369.71135.50.38
2025-11-07EXAS66.18369.71176.60.38
2025-11-10EXAS66.58369.71181.00.38
2025-11-11EXAS67.50389.61182.60.43
2025-11-12EXAS68.38389.61182.40.43
2025-11-13EXAS67.78389.61178.00.43
2025-11-14EXAS67.04389.61177.60.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20EXAS-0.31-5.763.60
2025-10-21EXAS-0.31-5.763.60
2025-10-22EXAS-0.31-5.763.60
2025-10-23EXAS-0.31-5.763.60
2025-10-24EXAS-0.31-5.763.60
2025-10-27EXAS-0.31-6.134.27
2025-10-28EXAS-0.77-6.134.27
2025-10-29EXAS-0.77-6.134.27
2025-10-30EXAS-0.77-6.134.27
2025-10-31EXAS-0.77-6.134.27
2025-11-03EXAS-0.77-7.104.27
2025-11-04EXAS-0.78-7.104.27
2025-11-05EXAS-0.78-7.104.27
2025-11-06EXAS-0.78-7.104.26
2025-11-07EXAS-0.94-7.104.26
2025-11-10EXAS-0.94-7.084.26
2025-11-11EXAS-0.94-7.084.26
2025-11-12EXAS-0.94-7.084.25
2025-11-13EXAS-0.94-7.084.25
2025-11-14EXAS-0.94-7.084.25
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.24

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.08

Insider Transactions

-0.94

Institutional Transactions

-7.08

Beta

1.45

Average Sales Estimate Current Quarter

859

Average Sales Estimate Next Quarter

830

Fair Value

45.57

Quality Score

37

Growth Score

48

Sentiment Score

43

Actual DrawDown %

58

Max Drawdown 5-Year %

-80.4

Target Price

83.65

P/E

Forward P/E

219.17

PEG

P/S

4.12

P/B

5.08

P/Free Cash Flow

51.4

EPS

-5.32

Average EPS Est. Cur. Y​

0.43

EPS Next Y. (Est.)

1.11

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

-32.01

Relative Volume

0.65

Return on Equity vs Sector %

-66.3

Return on Equity vs Industry %

-50.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

1177.6
Exact Sciences Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 6900
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today
news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance
stock history EXAS – Exact Sciences Corporation invest stock market
stock prices EXAS premarket after hours
ticker EXAS fair value insiders trading